Well Pharmacy has announced the acquisition of Lexon UK Holdings and Asurex Limited, a family-owned pharmaceutical wholesaler with five depots in Redditch,
Leeds, Durham, East Kilbride and Dublin and a network of community pharmacies across the Midlands, Northwest, and Northeast of England.
Lexon, is a family-owned business which has been in operation for over 25 years, running primarily as a pharmaceutical wholesaler for 3,000 retail pharmacy
customers across the UK and Ireland.
The business also operates 42 community pharmacies - currently trading as Knights Pharmacy - and is also a specialist developer and manufacturer of generic
pharmaceuticals and is a data and solutions provider to pharmacy.
The acquisition will be notified to the Competition and Markets Authority (CMA).
Both parties have proactively engaged with the CMA in pre-notification discussions and look forward to continuing to do so productively during the CMA review period.
Haider Choudrey, CFO of Bestway Group which own Well Pharmacy, said: "Through this acquisition we seek to augment our growth momentum and bring in even greater
benefits to both community pharmacies and patients. Well Pharmacy had been searching for a target to expand its footprint and complement its growth trajectory and
we are confident that Lexon fits this criterion."
Bestway operates approximately 750 pharmacies nationwide in the UK under the Well brand. In April 2023, it completed its acquisition of Lexon, which operates
46 pharmacies in the UK under the Knights Pharmacy brand, and Asurex, a wholesale perfume supplier.
On 26th May 2023, CMA announced the launch of its merger inquiry. A fast-track Phase 1 investigation found that the merger could lead to a significant lessening of
competition between retail pharmacies in 12 local areas located in Liverpool and North East England.
The merging businesses conceded that the deal raises competition concerns in these areas and have submitted proposals to sell pharmacies within these areas to
restore the competition that would otherwise be lost as a result of the deal.
Colin Raftery, CMA Senior Director of Mergers, said: "Pharmacies are essential public health services, and it's vital that the loss of competition brought about
by a deal like this shouldn't leave people with reduced choice or worse services when they need medical support.
The CMA will now carefully consider whether the remedy put forward by Bestway will address its concerns and ensure that customers in the affected areas continue to
have access to good quality chemists.
Well Pharmacy has announced a new partnership with RangeMe, a product discovery, sourcing and purchasing platform, as it looks to increase the diversity of
products available to its customers.
The independent pharmacy chain said the partnership will provide new, emerging and diverse brands increased access to its buying teams. There are already over
200,000 suppliers registered on the RangeMe platform.
"We pride ourselves on being at the heart of the communities we serve and are delighted to be working with RangeMe to increase the diversity of the products we
are able to offer to our customers across the UK," Reena Takhar, head of OTC & NHS buying at Well Pharmacy said.
"Given the ongoing cost-of-living crisis, we're keen to do all we can to give businesses of all sizes the opportunity to connect with our buyersto allow us to
offer new and interesting great value products to our customers."
RangeMe helps retailers and their buying teams scale product sourcing efforts with streamlined submissions, simplified discovery tools, and the industry standard
digital sell sheet.
In many cases, a pharmacy's most valuable asset is its NHS contract. This is what buyers are paying for - the right to provide pharmaceutical services
commissioned by the NHS and be reimbursed for the medicines dispensed.
However, a pharmacy consists of more than just an NHS contract and when buyers look for a pharmacy to buy, they will also examine these other areas - the pharmacy's
customer base, its staff, the property it operates from - to name a few - because these are all also crucial to a successful pharmacy.
In this day and age, another important consideration is the pharmacy's intellectual property (IP) i.e. the pharmacy's rights to certain types of information, ideas,
and forms of expression. At the most basic level, this includes the trade mark in the name of the pharmacy, because all pharmacies will have a name by which they
distinguish themselves from other pharmacies. The more well-known the name, the more valuable this form of IP is - mention 'Boots', for example, and most will have
an instant association with the largest pharmaceutical retailer in the UK.
Superdrug, one of the leading health and beauty retailers, is all set to invest in 25 new stores this year, expanding its bricks-and-mortar retail footprint.
It confirmed with Pharmacy Business that amongst its 25 new stores there "will be a mix of pharmacy and retail stores".
The venture is expected to create over 570 jobs nationwide, creating a seamless customer experience and providing vital support for high streets and local
communities.
The investment, part of the brand's O+O (Online + Offline) platform strategy to deliver its omnichannel ambitions, is driven by continued strong performance
figures. In Q4 2022 Superdrug reported increased volume and value sales and footfall across both sides of the beauty and health business. Whilst in 2021 revenue
rose 5.1% to £1,168million with a profit before tax increase of 141.3%.
The investment strategy has already seen Superdrug open new stores in Washington Gallery and Falkirk Retail Parks in February 2023 and in Braehead, the largest
Superdrug in Scotland, just last month.
One evening whilst I was watching TV, my phone pinged with an all too familiar WhatsApp alert with a message preview saying "Can you help". I recognised the
name as one of our Titan pharmacy customers who was clearly in a state of panic.
I replied offering my assistance and asked him what was up. What followed over the next 24 hours was an interesting case study of how innovative technology can
genuinely solve real challenges in pharmacies.
Mr P (let's call him that) had booked a locum to cover in his dispensary on the next day so he could focus on his vaccination service. The problem - his locum
had just called to cancel his booking (no reason given) and now he had no cover.
Meanwhile, he was fully booked with back to back appointments and could not cancel them. He had phoned round his usual network of pharmacists and no one was
available at short notice.
He was asking if there was anything that Titan could do to reduce his workload and said he had heard about Titan's artificial intelligence module.
Unfortunately, Titan. X had not been installed at this site and was not an option at this late stage.
Equally, Titan's digital workflow cannot be circumvented so there was no way steps could be taken out of the process.
Online retail giant Amazon said on Tuesday (January 24) it is offering a $5 monthly subscription plan for U.S. Prime members that will cover a range of generic
drugs and their doorstep delivery, furthering the ecommerce giant's push into healthcare.
The program, named RxPass, includes more than 50 medications addressing over 80 chronic conditions such as high blood pressure, anxiety, diabetes and male pattern
baldness, Vin Gupta, Amazon Pharmacy's chief medical officer, has said.
However, customers enrolled in Medicare, Medicaid or any other government healthcare program will not be able to enrol in Amazon Pharmacy's RxPass service.
The average Prime member would save about $100 per year with RxPass, John Love, vice president of Amazon Pharmacy, said. Amazon Prime members in most U.S. states
can sign up for the program from January 24.
The flat $5 charge would be without insurance and on top of the Prime membership fee, which costs $139 per year in the United States.
High street pharmacy giant Boots permanently shut down two more branches on Saturday (March 16) as it moves forward with its plan to close 300 stores.
The Wrightson House branch at the Pavilion Shopping Centre in Teesside and the Aslake Close pharmacy in Sprowston were closed for good, according to BirminghamLive.
The pharmacy giant and chemist announced that all their prescriptions from its branch in Sprowston will be moved to Lawson Road Health Centre, with the nearest
Boots branches located in London Street and Aylsham Road.
The closure of the branch at the Pavilion Shopping Centre in Teesside was confirmed to the public with a notice placed in the shop window, informing customers
about nearby Boots stores to collect their prescriptions.
The notice reads: "We are closing. This store will close, on March 16, 2024. Your nearest store for collecting prescriptions will be Thornaby Health Centre,
Trenchard Avenue, TS17 OEE. Other stores nearby are: 12-14 High Street, Teesside Retail Park, Norton, TS20 1DN 21B Goodwood Square, TSI7 7BW."
European asset management group Aurelius has completed the acquisition of McKesson UK, marking the company's fifth completed transaction in a year.
McKesson UK is the parent company of a number of healthcare businesses including LloydsPharmacy, John Bell & Croyden and AAH Pharmaceuticals.
It comprises four divisions and holds a substantial market share across each vertical: retail, digital, homecare and wholesale. McKesson UK's success has been underpinned by its strong LloydsPharmacy brand, its customer base and its leading commercial footprint across wholesale pharmaceuticals.
Over recent years, the company has benefited from the introduction of additional services delivered across its more than 1,300 pharmacies, a growing digital offering and the ability to support the increasing trend of primary care being delivered to patients in their home.
Boots customers were left disappointed as the retail giant closed three more branches, two in Kent and one in Glasgow.
On Sunday 21 January, Boots' branches in Cliftonville and Biggin Hill were closed, forcing locals to find an alternative pharmacy, Express.co.uk reported.
Cliftonville residents have taken to social media to express their disappointment over the closure of their local pharmacy on Northdown Road.
Even though there is another Boots branch in Margate, they said that Cliftonville branch is "much more accessible, with parking available right outside, on
the bus route and surrounded by a residential area within easy walking distance."
One resident has branded the retailer's decision as "crazy", as per the news portal.
Boots has partnered with Uber Eats to deliver beauty essentials and healthcare products to customers' doors in 30 minutes.
Medicines for minor ailments such as coughs, colds, hay fever, mild pain, rashes as well as COVID-19 test kits can be ordered through Uber Eats.
Boots is partnering with the doorstep delivery company with a pilot in 14 of its stores around the UK, with 13 of those stores giving customers within range
access to third-party doorstep delivery of Boots products for the very first time.
Uber Eats customers within range of participating Boots stores can choose from more than 900 products available for delivery straight to their homes or workplace,
including toiletries, medicines for minor ailments, food and drink options, and best-selling beauty and gifting options perfect for a last-minute gift or treat.
Paula Bobbett, Chief Digital Officer at Boots said: "We are hugely excited to be launching our partnership with Uber Eats. As the first health and beauty retailer
on its platform, we can offer an extensive range of product options to customers for delivery straight to their door. Whether it's medicines for mild illnesses or
last-minute gifts, beauty items or top-ups of a favourite skincare brand, we can meet all our customers' needs both quickly and conveniently."
Boots witnessed a 'record-breaking' performance for beauty driving retail sales with a growth of 16 per cent in the three months to 28 February 2023.
The beauty category delivered a record January, and premium beauty saw its biggest ever sales week in December. Skincare reported three consecutive weeks of record
sales in December driven by the 'expert skincare' category in which brands including No7, La Roche-Posay, CeraVe and Eucerin proved popular.
Boots beauty transformation strategy continued with 19 new beauty halls opened in Q2 and the 170th store to receive a beauty makeover opening at Westfield White City
post-period end. Boots now stocks over 500 big name and cult beauty brands and exclusively sells the UK's leading skincare brand, No7.
The business reported its eighth consecutive quarter of market share growth with gains across all categories, led by beauty - the stand-out performer of the quarter.
Footfall, basket size and the number of Advantage Card customers all increased, as more people chose to shop at Boots. The Christmas period was particularly strong
with retail sales in the five weeks to 31 December up 17.4% and outperforming the market.
Boots further expanded its value offering in the quarter, announcing its biggest ever savings as part of its continued focus on the affordability of life's essentials.
This included the addition of 60 new products to the Boots Everyday label as well as the extension of its Price Advantage scheme, which has to date resulted in £30
million of customer savings and now includes discounts on over 800 products every month.
Walgreens Boots Alliance, Boots UK's parent company, has appointed Tim Wentforth as its new CEO, effective on 23 October.
He joined WBA at a pivotal time when the company plans to downsize the business while driving execution and creating greater value for employees, patients,
customers and shareholders.
Wentforth replaced Rosalind Brewer, who stepped down on 1 September, after two years at the helm.
He joined from Evernorth, Cigna's health services organisation based in Connecticut, where he served as its founding CEO.
Prior to Cigna, he also held top roles in companies including specialty pharmacy company Accredo and pharmacy benefit manager Express Scripts.
Holland & Barrett, the UK's leading wellness retailer, has become the latest retailer regulatory member of PAGB, the consumer healthcare association.
PAGB represents the manufacturers of branded over-the-counter (OTC) medicines, self care medical devices and food supplements in the UK.
Holland & Barrett's decision to PAGB follows its recent introduction of a selected range of OTC and healthcare products in its stores across the UK. These
include painkillers, cough and cold medicines, children's health essentials, hay fever relief, as well as skin and gastrointestinal products.
With this expansion, the retailer aims to not only help customers to stay well, but also provide relief when needed.
Well Pharmacy's parent company, Bestway Group, announced on Wednesday (20 March) that it recorded a five per cent growth in revenues to £4.74 billion for
the year ending June 2023, alongside a pre-tax profit of £420.9 million.
During the year, the company also completed acquisition of Lexon UK Holdings, a leading pharmaceutical wholesaler serving over 3,000 retail pharmacy customers
across the UK and Eire.
Furthermore, the Group completed the construction of two cement plants in Pakistan, bringing its total cement manufacturing capacity to 15.3 million tonnes per
annum.
Sir Anwar Pervez OBE, founder and chairman of Bestway Group, expressed optimism about the new business year and said: "The Group has continued on its growth
trajectory in 2023 and we are confident that our businesses will continue to gain share within their respective markets during 2024."
Teva UK has begun replacing its existing packaging with a new design which is "clearer and easier to read".
The new look is "unique, recognisable and distinctive." It "enhances safety and provides a recognisable and distinguishable pack range."
One of the UK's leading generics manufacturers, Teva UK supplies more than 500 generic pharmaceutical products to retail and hospital pharmacies.
The company says each product within the portfolio is distinguishable by colour, ensuring no two different packs have the same drug and strength colours and with
additional product information on the side of the pack and a simplified back, it makes it even easier to identify the correct product when dispensing and supports
patients when taking their medication.
"Our medicines impact the lives of millions of people every day and our packaging is often the first touchpoint for our patients and our customers", said Kim Innes,
general manager of Teva UK and Ireland.